80 listed Pharmaceuticals companies ranked by operating income, from EDINET annual securities reports. Values in absolute JPY.
Also rank this industry: by Revenue · by Total Assets
| # | Company | Operating Income |
|---|---|---|
| 1 | CHUGAI PHARMACEUTICAL CO., LTD. (4519) | ¥598,833,000,000 (≈ ¥0.60T) |
| 2 | Otsuka Holdings Co., Ltd. (4578) | ¥479,375,000,000 (≈ ¥0.48T) |
| 3 | Astellas Pharma Inc. (4503) | ¥382,633,000,000 (≈ ¥0.38T) |
| 4 | DAIICHI SANKYO COMPANY, LIMITED (4568) | ¥229,089,000,000 (≈ ¥0.23T) |
| 5 | Shionogi & Co.,Ltd. (4507) | ¥166,725,000,000 (≈ ¥0.17T) |
| 6 | Sumitomo Pharma Co., Ltd. (4506) | ¥107,338,000,000 (≈ ¥0.11T) |
| 7 | ONO PHARMACEUTICAL CO., LTD. (4528) | ¥92,236,000,000 (≈ ¥0.09T) |
| 8 | SANTEN PHARMACEUTICAL CO.,LTD. (4536) | ¥47,797,000,000 (≈ ¥0.05T) |
| 9 | Eisai Co., Ltd. (4523) | ¥44,138,000,000 (≈ ¥0.04T) |
| 10 | ROHTO PHARMACEUTICAL CO.,LTD. (4527) | ¥41,118,000,000 (≈ ¥0.04T) |
| 11 | Nippon Shinyaku Co.,Ltd. (4516) | ¥35,496,000,000 (≈ ¥0.04T) |
| 12 | TSUMURA & CO. (4540) | ¥35,219,000,000 (≈ ¥0.04T) |
| 13 | TOWA PHARMACEUTICAL CO.,LTD. (4553) | ¥23,102,000,000 (≈ ¥0.02T) |
| 14 | SAWAI GROUP HOLDINGS Co., Ltd. (4887) | ¥15,894,000,000 (≈ ¥0.02T) |
| 15 | ZERIA PHARMCEUTICAL CO., LTD. (4559) | ¥12,374,444,000 (≈ ¥0.01T) |
| 16 | Mochida Pharmaceutical Co.,Ltd. (4534) | ¥10,147,000,000 (≈ ¥0.01T) |
| 17 | TAUNS Laboratories, Inc. (197A) | ¥8,265,025,000 |
| 18 | Takeda Pharmaceutical Company Limited (4502) | ¥6,217,000,000 |
| 19 | ASKA Pharmaceutical Holdings CO., Ltd. (4886) | ¥5,834,000,000 |
| 20 | KOA SHOJI HOLDINGS CO.,LTD. (9273) | ¥5,355,182,000 |
| 21 | Fuji Pharma Co.,Ltd. (4554) | ¥4,990,000,000 |
| 22 | MIZUHO MEDY CO.,LTD. (4595) | ¥4,646,000,000 |
| 23 | KYORIN Pharmaceutical Co., Ltd. (4569) | ¥3,567,000,000 |
| 24 | EIKEN CHEMICAL CO.,LTD. (4549) | ¥2,919,000,000 |
| 25 | Fuso Pharmaceutical Industries,Ltd. (4538) | ¥2,639,000,000 |
| 26 | Daito Pharmaceutical Co., Ltd. (4577) | ¥2,619,000,000 |
| 27 | MORISHITA JINTAN CO.,LTD. (4524) | ¥692,000,000 |
| 28 | JCR Pharmaceuticals Co.,Ltd. (4552) | ¥555,000,000 |
| 29 | RaQualia Pharma Inc. (4579) | ¥483,719,000 |
| 30 | TAIKO PHARMACEUTICAL CO., LTD. (4574) | ¥459,000,000 |
| 31 | MUROMACHI CHEMICALS INC. (4885) | ¥432,188,000 |
| 32 | YUKI GOSEI KOGYO CO.,LTD. (4531) | ¥383,000,000 |
| 33 | Kohjin Bio Co., Ltd. (177A) | ¥341,536,000 |
| 34 | Immuno-Biological Laboratories Co., Ltd. (4570) | ¥281,277,000 |
| 35 | Ｈｅａｒｔｓｅｅｄ株式会社 (219A) | ¥272,156,000 |
| 36 | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) | ¥255,542,000 |
| 37 | StemCell Institute Inc. (7096) | ¥202,657,000 |
| 38 | NIPPON CHEMIPHAR CO., LTD. (4539) | ¥179,000,000 |
| 39 | CHUKYOIYAKUHIN CO.,LTD. (4558) | ¥127,424,000 |
| 40 | Kidswell Bio Corporation (4584) | ¥-138,510,000 |
| 41 | Renascience Inc. (4889) | ¥-356,885,000 |
| 42 | 株式会社Ｖｅｒｉｔａｓ Ｉｎ Ｓｉｌｉｃｏ (130A) | ¥-396,748,000 |
| 43 | D.Western Therapeutics Institute, Inc. (4576) | ¥-619,870,000 |
| 44 | SEIKAGAKU CORPORATION (4548) | ¥-660,000,000 |
| 45 | TMS Co., Ltd (4891) | ¥-696,973,000 |
| 46 | Perseus Proteomics Inc. (4882) | ¥-744,955,000 |
| 47 | ステラファーマ株式会社 (4888) | ¥-748,957,000 |
| 48 | 株式会社ＰＲＩＳＭ ＢｉｏＬａｂ (206A) | ¥-774,453,000 |
| 49 | ノイルイミューン・バイオテック株式会社 (4893) | ¥-797,255,000 |
| 50 | OncoTherapy Science, Inc. (4564) | ¥-810,385,000 |
| 51 | 株式会社サイフューズ (4892) | ¥-828,179,000 |
| 52 | ソレイジア・ファーマ株式会社 (4597) | ¥-861,000,000 |
| 53 | Kubota Pharmaceutical Holdings Co., Ltd. (4596) | ¥-894,855,000 |
| 54 | KAKEN PHARMACEUTIAL CO., LTD. (4521) | ¥-899,000,000 |
| 55 | Kringle Pharma,Inc. (4884) | ¥-909,452,000 |
| 56 | K Pharma,Inc. (4896) | ¥-916,056,000 |
| 57 | 株式会社メドレックス (4586) | ¥-941,999,000 |
| 58 | Nano Holdings, Inc. (4571) | ¥-965,988,000 |
| 59 | Chiome Bioscience Inc. (4583) | ¥-979,774,000 |
| 60 | Cuorips Inc. (4894) | ¥-1,081,266,000 |
| 61 | CanBas Co.,Ltd. (4575) | ¥-1,109,563,000 |
| 62 | RIBOMIC Inc. (4591) | ¥-1,207,132,000 |
| 63 | BrightPath Biotherapeutics Co., Ltd. (4594) | ¥-1,295,001,000 |
| 64 | Delta-Fly Pharma, Inc. (4598) | ¥-1,605,088,000 |
| 65 | 株式会社ファンペップ (4881) | ¥-1,648,668,000 |
| 66 | Chordia Therapeutics,Inc (190A) | ¥-1,789,781,000 |
| 67 | StemRIM Inc. (4599) | ¥-1,971,532,000 |
| 68 | Oncolys BioPharma Inc. (4588) | ¥-2,024,068,000 |
| 69 | Carna Biosciences, Inc. (4572) | ¥-2,074,972,000 |
| 70 | Modalis Therapeutics Corporation (4883) | ¥-2,211,801,000 |
| 71 | イノバセル株式会社 (504A) | ¥-2,231,686,000 |
| 72 | KISSEI PHARMACEUTICAL CO.,LTD. (4547) | ¥-2,927,000,000 |
| 73 | HEALIOS K.K. (4593) | ¥-3,340,000,000 |
| 74 | GNI Group Ltd. (2160) | ¥-3,471,000,000 |
| 75 | J-Pharma Co.,Ltd. (520A) | ¥-3,710,176,000 |
| 76 | SanBio Company Limited (4592) | ¥-3,794,811,000 |
| 77 | SymBio Pharmaceuticals Limited (4582) | ¥-4,440,687,000 |
| 78 | PeptiDream Inc. (4587) | ¥-5,013,195,000 |
| 79 | AnGes, Inc. (4563) | ¥-5,145,393,000 |
| 80 | Nxera Pharma Co., Ltd. (4565) | ¥-8,462,000,000 |
Free 5-year dataset on Kaggle / Hugging Face; full 3,600-company pack on Gumroad.
Ranking size proxied by revenue where market cap is unavailable. Not investment advice.